GSK Malta launches improved website to test Asthma control

Asthma is a common and treatable disease which can impact heavily on quality of life. Medical experts now agree that the level of asthma control is a key feature when determining the best asthma treatment required. In Europe, at least 50% of patients have poor control of their asthma, despite the availability of treatments to help manage their condition.

For World Asthma Day 2016, on 3rd May, GlaxoSmithKline (GSK) Malta has launched a new and improved website to provide asthma sufferers and their doctors with a useful score to help them determine the level of treatment required.

The asthma control test was conceived by medical asthma experts and scientifically tested on hundreds of asthmatic sufferers.

Some of the new asthma control test features include compatibility with any digital device with access to internet, reduced test time, printable results, and availability for both children and adults.

GSK contributed to the development of the asthma control test (www.asthmacontroltest.com). Maltese patients are encouraged to take this online test which takes less than a minute.